MC
YCBD icon

Merlin Capital’s cbdMD YCBD Stock Holding History

Merlin Capital’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,147
Closed -$257K – 72
2022
Q4 		$257K Buy
3,147
+838
+36% +$84.4K 0.63% 64
2022
Q3 		$187K Sell
2,309
-1,164
-34% -$167K 0.43% 68
2022
Q2 		$550K Sell
3,473
-1,426
-29% -$338K 1.1% 34
2022
Q1 		$1.83M Buy
4,899
+394
+9% +$133K 2.42% 13
2021
Q4 		$1.75M Buy
+4,505
New +$2.62M 2.02% 14

Other funds holding YCBD

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Merlin Capital's YCBD Position: Q1 2023 in Review

Merlin Capital sold out of cbdMD (YCBD) in Q1 2023, closing a stake of 3,147 shares — an estimated $257K sold.

Merlin Capital first reported a position in YCBD in Q4 2021 and held it in 5 quarters. The position peaked at $1.83M in Q1 2022. 43 funds tracked by Wall St. Rank hold YCBD as of Q1 2023.

  • Merlin Capital reported no remaining cbdMD position as of Q1 2023 after selling out during the quarter.
  • Merlin Capital sold 3,147 cbdMD shares in Q1 2023, an estimated $257K.
  • Merlin Capital first reported a position in cbdMD in Q4 2021 and held it in 5 quarters.
  • Merlin Capital's cbdMD position peaked at $1.83M in Q1 2022.
  • 43 funds tracked by Wall St. Rank held cbdMD as of Q1 2023.

Based on Merlin Capital's 13F filing for Q1 2023, filed 16 May 2023.